1.  北京市自然科学基金-海淀原始创新联合基金，重点项目，L252054，基于 PET/MRI的2型神经纤维瘤病肿瘤微环境时空异质性与精准治疗优化研究，2025.7-2028.6,100万元，在研。

2.   科技创新2030-“脑科学与类脑研究”，重大项目，2022ZD0211602，中国HEAD北部社区队列建设及AD早期预测和中医药干预研究，2022.8-2027.7，265万元，在研。

3.   北京市自然科学基金，面上项目，7192054，多模态PET/MRI对亚临床阿尔茨 海默病分子标记物沉积与脑拓扑结构变化的关联研究，2019-01至2021-12，20万元，已结题。

4.   国家自然科学基金，面上项目，81771143，轻度认知障碍患者默认网络失连 接与脑能量代谢的关联研究，2018-01至2021-12，54万元，已结题。

5.   国家重点研发计划，2018YFC1315201，基于大型前瞻性队列的临床前阿尔茨海默病综合预防与治疗的中美合作研究，2018-09至2020-06，53.78万元，已结题。

6.   国家重点基础研究发展计划，2015CB75500，脑胶质瘤精准诊疗技术的关键科学问题研究，2015-01至2019-08，3000万元，已结题。

7.   国家自然科学基金，面上项目，81071139，卒中后轻瘫恢复过程静息态有效 连接度运动网络的纵向研究，2011-01至2013-12，31万元，已结题。

8.   国家自然科学基金，面上项目，30770617，基于功能磁共振成像和脑磁图的缺血性脑卒中运动功能康复的纵向研究，2008-01至2010-12，36万元，已结题。

1.     Di Fan#,Xin Wang#, Xueyuan Ling, Hongbin Li, Lu Zhang, Wei Zheng, Zehui Wu*,Lin Ai*. Utilisation of the innovative 18F-labelled radiotracer18F-BIBD-071within HR+ breast cancer xenograft mouse models. Pharmaceuticals.2025,18(1):66.

2.     Ziyue Yu, ZengJiang, Xuebo Cheng, Leilei Yuan, Hualong Chen, Lin Ai, Zehui Wu. Developmentof fibroblast activation protein-α radiopharmaceuticals: Recent advances andperspectives. European journal of Medicinal Chemistry. 2024, 277:116787.

3.    Qiang Chen#, Kai Wang#,Xiaohui Ren, Xiaobin Zhao, Qian Chen, Di Fan, Shu Zhang, Xiaotong Li, Lin Ai. Individualizeddiscrimination of tumor progression from treatment-related changes in differenttypes of adult-type diffuse gliomas using 11C-methionine PET. Journal ofNeuro-Oncology. 2023,165(3):547-559.

4.    XiaobinZhao#, Deling Li#, Zhen Qiao, Kai Wang, Qian Chen,Changucn Pan, Yuliang Wu, Dan Xiao, Tianshu Xi, Liwei Zhang*, Lin Ai*.11C-methionine PET imaging characteristics in children withdiffuse intrinsic pontine gliomas and relationship to survival and H3 K27Mmutation status. European Journal of Nuclear Medicine and Molecular Imaging.2023,50(6):1709-1719.

5.    KaiWang, Xiaobin Zhao, Lielei Yuan, Qian Chen, Qun Wang, Lin Ai. CorticalMetabolic Characteristics of Anti-Leucine-Rich Glioma-Inactivated 1 AntibodyEncephalitis Based on 18F-FDG PET. Frontiers in Neurology.2023,14:1100760.

6.    ShuZhang, Jie Wang, Kai Wang, Xiaotong Li, Xiaobin Zhao, Qian Chen, Wei Zhang, Lin Ai. Differentiationof high-grade glioma and primary central nervous system lymphoma:Multiparametric imaging of the enhancing tumor and peritumoral regions based onhybrid 18F-FDG PET/MRI. European Journal of Radiology.2022,150:110235.

7.    Zhen Qiao, Guihong Wang, Xiaobin Zhao,Kai Wang, Di Fan, Qian Chen, Lin, Ai. Neuropsychological Performance IsCorrelated With Tau Protein Deposition and Glucose Metabolism in Patients WithAlzheimer's Disease. Frontiers in Aging Neuroscience. 2022,14:841942.

8.    KaiWang, Zhen Qiao, Xiaobin Zhao, Xiaotong Li, Xin Wang, Tingfan Wu, Zhongwei Chen,Di Fan, Qian Chen, Lin Ai. Individualized discrimination of tumorrecurrence from radiation necrosis in glioma patients using an integratedradiomics-based model. European Journal of Nuclear Medicine and MolecularImaging. 2020, 47(6): 1400-1411.

9.    ZhihongShi#, Liping Fu#, Nan Zhang#, Xiaobin Zhao#, Shuai Liu, Chuantao Zuo, Li Cai,Ying Wang, Shuo Gao, Lin Ai*, Yihui Guan*, Baixuan Xu*, Yong Ji*. Amyloid PET in Dementia Syndromes: A ChineseMulticenter Study. Journal of Nuclear Medicine. 2020,61(12): 1814-1819.

10. DiFan, Kai Wang, Nannan Gao, Qi Luo, Xin Wang, Xiaotong Li, Wu Tong, Xin Zhang,Chuangwei Luo, Guangjie Yang, Lin Ai*, Jiyun Shi*. A 64Cu-porphyrin-based dual-modalmolecular probe with integrin αvβ3 targeting function for tumor imaging. Journalof Labelled Compounds & Radiopharmaceuticals. 2020, 63(5): 212-221.

11. XiaoLiu, Wei Shan, Xiaobin Zhao, Jiechuan Ren, Guoping Ren, Chao Chen, WeixiongShi, Ruijuan Lv, Zhimei Li, Yaou Liu, Lin Ai*, Qun Wang*. The ClinicalValue of 18F-FDG-PET in Autoimmune Encephalitis Associated With LGI1 Antibody. Frontiersin Neurology. 2020, 11:418.

12. XiSun#, Binbin Nie#, Shujun Zhao, Qian Chen, PanlongLi, Tianhao Zhang, Tingting Pan, Ting Feng, Luying Wang, Xiaolong Yin, WeiZhang, Shilun Zhao, Baoci Shan, Hua Liu*, Shengxiang Liang*, Lin Ai*, Guihong Wang*. Tau PET Distributional Pattern inAD Patients with Visuospatial Dysfunction. Current Alzheimer Research.2019, 16(11): 1055-1062.

13. ZhenQiao#,Xiaobin Zhao#,Kai Wang, Yongzhong Zhang, Di Fan, Tao Yu, Huicong Shen, Qian Chen, Lin Ai.Utility of Dynamic Susceptibility Contrast Perfusion-Weighted MR Imaging and11C-Methionine PET/CT for Differentiation of Tumor Recurrence from RadiationInjury in Patients with High-Grade Gliomas. American Journal ofNeuroradiology. 2019, 40(2): 253-259.

14. KaiWang, Xiaobin Zhao, Qian Chen, Di Fan, Zhen Qiao, Song Lin, Tao Jiang, JianpingDai, Lin Ai. A new diagnostic marker for differentiating multicentricgliomas from multiple intracranial diffuse large B-cell lymphomas on 18F-FDGPET images. Medicine. 2017, 96(32):e7756.

15. PeifenChang#, Xin Li#, Chao Ma#, Sisi Zhang, Zhen, Liu, Kewei Chen, Lin Ai*,Jingling Chang*, Zhanjun Zhang. The Effects of an APOE Promoter Polymorphism onHuman White Matter Connectivity during Non-Demented Aging. Journal ofAlzheimers Disease. 2017, 55(1):77-87.